Liarozole dihydrochloride
Tocris Bioscience, part of Bio-Techne | Catalog # 2705
Blocks retinoic acid metabolism
Key Product Details
Description
Blocks retinoic acid metabolism
Alternative Names
R-75251
Product Description
Liarozole dihydrochloride is a cytochrome P450 inhibitor. Inhibits several cytochrome P450 enzymes including aromatase (CYP19) and retinoic acid 4-hydroxylase (CYP26). Blocks retinoic acid metabolism (retinoic acid metabolism blocking agent, RAMBA). Displays antitumor activity against androgen-dependent and independent rat prostate carcinomas.Product Specifications
Molecular Weight
381.69
Formula
C17H13ClN4.2HCl
Storage
Desiccate at RT
Purity
≥98% (HPLC)
Chemical Name
5-[(3-Chlorophenyl)-1H-imidazol-1-ylmethyl]-1H-benzimidazole dihydrochloride
CAS Number
1883548-96-6
PubChem ID
121513844
InChI Key
NKDMRTVUEJWCCQ-UHFFFAOYSA-N
SMILES
ClC1=CC(C(N4C=CN=C4)C2=CC=C(N=CN3)C3=C2)=CC=C1.Cl.Cl
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 34.52 | 100 | |
| DMSO | 38.17 | 100 |
Preparing Stock Solutions
for Liarozole dihydrochloride
The following data is based on the product molecular weight 381.69
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.62 mL | 13.10 mL | 26.20 mL |
| 5 mM | 0.52 mL | 2.62 mL | 5.24 mL |
| 10 mM | 0.26 mL | 1.31 mL | 2.62 mL |
| 50 mM | 0.05 mL | 0.26 mL | 0.52 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Njar Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg.Med.Chem. 2006 PMID: 16530416
- Goss Effects of liarozole fumarate (R85246) in combination with tamox. on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model. BMC Cancer 2007 PMID: 17266767
- Van Wauwe Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo. J.Pharmacol.Exp.Ther. 1992 PMID: 1374473
Product Specific Notices for Liarozole dihydrochloride
For research use only
Loading...
Loading...